A Romanian study on the impact of glypressin in laparoscopic myomectomy

Matasariu,Daniela Roxana; Ursache,Alexandra; Himiniuc,Loredana; Toma,Bogdan; Boiculese,Vasile Lucian; Rudisteanu,Dorina; Dumitrascu,Irina

doi:10.3892/etm.2021.10387

A Romanian study on the impact of glypressin in laparoscopic myomectomy

Authors:
- Daniela Roxana Matasariu
- Alexandra Ursache
- Loredana Himiniuc
- Bogdan Toma
- Vasile Lucian Boiculese
- Dorina Rudisteanu
- Irina Dumitrascu
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania, Department of Preventive Medicine and Interdisciplinarity Medical Informatics and Biostatistics, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania, Department of Obstetrics and Gynecology, ‘Cuza Voda’ Obstetrics and Gynecology Clinical Hospital, 700038 Iasi, Romania
Published online on: July 6, 2021 https://doi.org/10.3892/etm.2021.10387
Article Number: 955
Copyright: © Matasariu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A major myomectomy‑associated problem is excessive blood loss. The aim of the present study was to evaluate the effect of glypressin on blood loss during laparoscopic myomectomy (LM) in women with uterine myomas. A total of 188 women scheduled for LM for uterine myomas were divided into two groups. The one group of women (n=64) received a 5‑ml intramyometrial injection of glypressin 0.2 mg/ml (glypressin group; group 1). The other group of women (n=124) (group 2) had an LM performed without any other method to reduce blood loss. The decrease in postoperative hemoglobin (Hb), hematocrit (Ht), morbidity and duration of hospital stay were assessed. The results revealed that Hb and Ht (as it was presumed) exhibited similar changes in our study. Statistically significant differences (P<0.05) were obtained between the two groups in terms of Hb and Ht; after LM both Hb and Ht were decreased. In conclusion, the impact of glypressin administration in hemorrhage control in uterine leiomyomas may establish new future perspectives, regarding its administration in gynecological hemorrhagic pathologies.

View Figures

View References

1	Zhang R, Shi H, Ren F and Yuan Z: Assessment of carboprost tromethamine for reducing hemorrhage in laparoscopic intramural myomectomy. Exp Ther Med. 10:1171–1174. 2015.PubMed/NCBI View Article : Google Scholar
2	Kongnyuy EJ and Wiysonge CS: Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev. 8(CD005355)2014.PubMed/NCBI View Article : Google Scholar
3	Srivastava S, Mahey R, Kachhawa G, Bhatla N, Upadhyay AD and Kriplani A: Comparison of intramyometrial vasopressin plus rectal misoprostol with intramyometrial vasopressin alone to decrease blood loss during laparoscopic myomectomy: Randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 228:279–283. 2018.PubMed/NCBI View Article : Google Scholar
4	Baird DD, Dunson DB, Hill MC, Cousins D and Schectman JM: High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 188:100–107. 2003.PubMed/NCBI View Article : Google Scholar
5	Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S and Bulletti Flamigni C: Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: A randomized comparison with abdominal myomectomy. Hum Reprod. 15:2663–2668. 2000.PubMed/NCBI View Article : Google Scholar
6	Rovio PH and Heinonen PK: Transvaginal myomectomy with screw traction by colpotomy. Arch Gynecol Obstet. 273:211–215. 2006.PubMed/NCBI View Article : Google Scholar
7	Fukuda M, Tanaka T, Kamada M, Hayashi A, Yamashita Y, Terai Y and Ohmichi M: Comparison of the perinatal outcomes after laparoscopic myomectomy versus abdominal myomectomy. Gynecol Obstet Invest. 76:203–208. 2013.PubMed/NCBI View Article : Google Scholar
8	Soto E, Flyckt R and Falcone T: Endoscopic management of uterine fibroids: An update. Minerva Ginecol. 64:507–520. 2012.PubMed/NCBI
9	Butala BP, Shah VR, Parikh BK, Jayaprakash J and Kalo J: Bradycardia and severe vasospasm caused by intramyometrial injection of vasopressin during myomectomy. Saudi J Anaesth. 8:396–398. 2014.PubMed/NCBI View Article : Google Scholar
10	Protopapas A, Giannoulis G, Chatzipapas I, Athanasiou S, Grigoriadis T, Kathopoulis N, Vlachos DE, Zaharakis D and Loutradis D: Vasopressin during laparoscopic myomectomy: Does it really extend its limits? J Minim Invasive Gynecol. 26:441–449. 2019.PubMed/NCBI View Article : Google Scholar
11	Koh MB and Hunt BJ: The management of perioperative bleeding. Blood Rev. 17:179–185. 2003.PubMed/NCBI View Article : Google Scholar
12	Trehan N: Laparoscopic myomectomy: Methods to control bleeding. J Gynecol Endosc Surg. 2:33–35. 2011.PubMed/NCBI View Article : Google Scholar
13	Wang CJ, Lee CL, Yuen LT, Kay N, Han CM and Soong YK: Oxytocin infusion in laparoscopic myomectomy may decrease operative blood loss. J Minim Invasive Gynecol. 14:184–188. 2007.PubMed/NCBI View Article : Google Scholar
14	Shimanuki H, Takeuchi H, Kitade M, Kikuchi I, Kumakiri J and Kinoshita K: The effect of vasopressin on local and general circulation during laparoscopic surgery. J Minim Invasive Gynecol. 13:190–194. 2006.PubMed/NCBI View Article : Google Scholar
15	Bhave Chittawar P, Franik S, Pouwer AW and Farquhar C: Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 10(CD004638)2014.PubMed/NCBI View Article : Google Scholar
16	Dubuisson JB, Chapron C, Fauconnier A and Babaki-Fard K: Laparoscopic myomectomy fertility results. Ann N Y Acad Sci. 943:269–275. 2001.PubMed/NCBI View Article : Google Scholar
17	Buckley VA, Nesbitt-Hawes EM, Atkinson P, Won HR, Deans R, Burton A, Lyons SD and Abbott JA: Laparoscopic myomectomy: Clinical outcomes and comparative evidence. J Minim Invasive Gynecol. 22:11–25. 2015.PubMed/NCBI View Article : Google Scholar
18	Kimura T, Kusui C, Matsumura Y, Ogita K, Isaka S, Nakajima A, Ohashi K, Koyama M, Azuma C and Murata Y: Effectiveness of hormonal tourniquet by vasopressin during myomectomy through vasopressin V1a receptor ubiquitously expressed in myometrium. Gynecol Obstet Invest. 54:125–131. 2002.PubMed/NCBI View Article : Google Scholar
19	Dubuisson J, Fauconnier A and Chapron C: Laparoscopic myomectomy. In: Atlas of Operative Laparoscopy and Hysteroscopy. 2nd edition. Donnez J and Nisolle M (eds). The Parthenon Publishing Group, New York, NY, pp215-224, 2001.
20	Zhao F, Jiao Y, Guo Z, Hou R and Wang M: Evaluation of loop ligation of larger myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy. Fertil Steril. 95:762–766. 2011.PubMed/NCBI View Article : Google Scholar
21	Liu WM, Tzeng CR, Yi-Jen C and Wang PH: Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids. Fertil Steril. 82:205–210. 2004.PubMed/NCBI View Article : Google Scholar
22	Dubuisson JB, Fauconnier A, Fourchotte V, Babaki-Fard K, Coste J and Chapron C: Laparoscopic myomectomy: Predicting the risk of conversion to an open procedure. Hum Reprod. 16:1726–1731. 2001.PubMed/NCBI View Article : Google Scholar
23	Frederick J, Fletcher H, Simeon D, Mullings A and Hardie M: Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br J Obstet Gynaecol. 101:435–437. 1994.PubMed/NCBI View Article : Google Scholar
24	Cohen SL, Senapati S, Gargiulo AR, Srouji SS, Tu FF, Solnik J, Hur HC, Vitonis A, Jonsdottir GM, Wang KC and Einarsson JI: Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: A randomised controlled trial. BJOG. 124:262–268. 2017.PubMed/NCBI View Article : Google Scholar
25	Riess ML, Ulrichs JG, Pagel PS and Woehlck HJ: Case report: Severe vasospasm mimics hypotension after high-dose intrauterine vasopressin. Anesth Analg. 113:1103–1105. 2011.PubMed/NCBI View Article : Google Scholar
26	Hobo R, Netsu S, Koyasu Y and Tsutsumi O: Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol. 113:484–486. 2009.PubMed/NCBI View Article : Google Scholar
27	Walid MS and Heaton RL: Laparoscopic myomectomy: An intent-to-treat study. Arch Gynecol Obstet. 281:645–649. 2010.PubMed/NCBI View Article : Google Scholar
28	Pirtea L, Balint O, Secosan C, Grigoras D and Ilina R: Laparoscopic resection of caesarian scar ectopic pregnancy after unsuccessful systemic methotrexate treatment. J Minim Invasive Gynecol. 26:399–400. 2019.PubMed/NCBI View Article : Google Scholar
29	Overdijk LE, Rademaker BMP, van Kesteren PJM, de Haan P, Riezebos RK and Haude OCH: The HYSTER study: The effect of intracervically administered terlipressin versus placebo on the number of gaseous emboli and fluid intravasation during hysteroscopic surgery: Study protocol for a randomized controlled clinical trial. Trials. 19(107)2018.PubMed/NCBI View Article : Google Scholar
30	Ryckwaert F, Virsolvy A, Fort A, Murat B, Richard S, Guillon G and Colson PH: Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: Consequences on heart perfusion and performance. Crit Care Med. 37:876–881. 2009.PubMed/NCBI View Article : Google Scholar